Stock ABOS ACUMEN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Acumen Pharmaceuticals, Inc.

Equities

ABOS

US00509G2093

Real-time Estimate Cboe BZX
Other stock markets
 15:25:54 13/05/2024 BST 		5-day change 1st Jan Change
3.455 USD +2.83% Intraday chart for Acumen Pharmaceuticals, Inc. -3.70% -10.72%
05-08 Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study MT
05-08 Acumen Pharmaceuticals, Inc. Announces First Patient Dosed in Altitude-Ad, A Phase 2 Clinical Trial of Sabirnetug in Early Alzheimer?S Disease CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acumen Pharmaceuticals, Inc. Appoints James Doherty as Its President and Chief Development Officer
CI
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to Its Board of Directors
CI
Acumen Pharmaceuticals, Inc. Announces Resignation of Dr. Jeffrey Sevigny to Its Board of Directors
CI
Acumen Pharmaceuticals, Inc. Announces Management Changes
CI
Acumen Pharmaceuticals Appoints Jeffrey Ives to the Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABOS Stock
  4. News Acumen Pharmaceuticals, Inc.
  5. Insiders